Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. A. Flentge
ABT-538 Is a Potent Inhibitor of Human Immunodeficiency Virus Protease and Has High Oral Bioavailability in Humans.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
TXU (Anti-Cd7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
